Based on TCGA data analyses of a dataset with >1000 breast cancer patients, MED1 was found to be altered (majorly amplifications) in upto 20% of these patients and its transcript levels correlated well with the copy number variations22,23. The gene discussed is MED1; the disease is breast carcinoma.